2025
Digital Immunoassay for Biomarker Detection Based on Single-Particle Laser Ablation ICP MS
SVOJANOVSKÝ, Vilém; Jakub MÁČALA; Antonin HLAVACEK; Ales CERMAK; Jaromír STRÁNÍK et al.Základní údaje
Originální název
Digital Immunoassay for Biomarker Detection Based on Single-Particle Laser Ablation ICP MS
Autoři
SVOJANOVSKÝ, Vilém; Jakub MÁČALA ORCID; Antonin HLAVACEK; Ales CERMAK; Jaromír STRÁNÍK; Pavel BOUCHAL; Ivana MAŠLAŇOVÁ; Petr SKLÁDAL; Zdeněk FARKA a Jan PREISLER
Vydání
ANALYTICAL CHEMISTRY, WASHINGTON, AMER CHEMICAL SOC, 2025, 0003-2700
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10406 Analytical chemistry
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.700 v roce 2024
Označené pro přenos do RIV
Ano
Organizační jednotka
Přírodovědecká fakulta
UT WoS
001518453500001
EID Scopus
2-s2.0-105009128321
Klíčová slova anglicky
Ablation; Assays; Immunoassays; Metal nanoparticles; Serum
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 8. 1. 2026 10:39, Mgr. Marie Novosadová Šípková, DiS.
Anotace
V originále
Single-particle (digital) immunoassays offer significantly lower limits of detection (LODs) than traditional immunoassays, making them suitable for the detection of low-abundance biomarkers. The most common approach for digital detection is based on counting individual labels. Here, we introduce a novel dot-blot particle-linked immunosorbent assay (PLISA) with digital readout utilizing laser ablation (LA) of photon upconversion nanoparticle (UCNP) labels from the nitrocellulose substrate. Compared to conventional LA, our approach allows desorption of intact nanoparticles and their precise counting by single-particle inductively coupled plasma mass spectrometry (SP ICP MS), thus counting individual UCNP-labeled immunocomplexes. Digital signal processing filters instrument noise and nanoparticle aggregates, minimizing potential errors. The immunoassay and LA SP ICP MS readout were optimized using human serum albumin, a kidney damage biomarker, as a model analyte, obtaining LODs of 0.18 and 0.12 ng/mL for the reference upconversion luminescence (UCL) and LA SP ICP MS readout, respectively. Building upon these optimized conditions, we developed PLISA for prostate-specific antigen, the key prostate cancer biomarker, with LODs of 2.4, 1.4, and 0.3 pg/mL for the UCL, analog, and digital LA SP ICP MS readout, respectively. The LOD in the sub-pg/mL range highlighted the advantage of particle counting and its ability to detect low-abundance biomarkers, as superior performance was achieved compared to the UCL and analog LA ICP MS readout. Finally, clinical serum samples of patients tested for prostate cancer were analyzed, and a strong correlation with the reference electrochemiluminescence method confirmed the potential of LA SP ICP MS for clinical diagnostics.
Návaznosti
| EF18_046/0015974, projekt VaV |
| ||
| EH23_015/0008175, projekt VaV |
| ||
| NU22-05-00042, projekt VaV |
| ||
| 90242, velká výzkumná infrastruktura |
|